Abstract
This study describes the formulation, physicochemical and mucoadhesive properties and in in vitro/in vivo release of chlorhexidine from mucoadhesive, polymeric compacts, designed for application within the oral cavity. Compacts were prepared by direct compression of mixtures containing 100 mg sodium carboxymethylcellulose (NaCMC), 25 mg hydroxyethylcellulose (HEC)/75 mg polyacrylic acid (PAA) and 75 mg HEC/25 mg PAA. The mechanical and mucoadhesive properties of the drug-loaded compacts were examined using a texture analyzer in compression and tension modes, respectively. Evaluation of mucoadhesion was performed using a mucin-coated gauze substrate. In vitro release of chlorhexidine was performed under sink conditions (phosphate buffered saline, pH 7.0, 37 °C) using a Caleva 7ST dissolution apparatus. Salivary chlorhexidine levels were determined following intra-oral placement of drug-containing formulations. Quantification of the mass of chlorhexidine released both in vitro and in vivo was performed using HPLC with ultraviolet detection. Furthermore, the in vivo acceptability of the various polymeric compacts was assessed in volunteers using standard questionnaires. Compacts composed of HEC/PAA exhibited greater in vivo retention than those composed of NaCMC. Compacts composed of 25 mg PAA and 75 mg HEC displayed greatest patient acceptability. Introduction of chlorhexidine into these compacts did not significantly compromise either the work required for compact fracture or the in vitro mucoadhesion. Controlled release of chlorhexidine from these compacts was observed both in vitro and in vivo, the concentration of chlorhexidine in saliva exceeding the minimum inhibitory concentration of the common oral pathogens over the study period. In light of the patient acceptability and in vivo performance, it is suggested that the compact composed of 25 mg PAA/75 mg HEC containing 10 mg chlorhexidine offers considerable promise for use as an antimicrobial agent in the oral cavity.
Similar content being viewed by others
References
I. M. Brook and R. Van Noort, Br. Dent. J. 157 (1984) 11.
D. S. Jones, A. D. Woolfson, J. Djokic and W. A. Coulter, Pharm. Res. 13(11) (1996) 1732.
D. S. Jones, A. D. Woolfson, A. F. Brown and M. J. O'Neill, J. Cont. Rel. 49(1) (1997) 71.
D. S. Jones, A. D. Woolfson and A. F. Brown, Pharm. Res. 15(7) (1998) 1131.
D. S. Jones, C. R. Irwin, A. D. Woolfson, J. Djokic and V. Adams, J. Pharm. Sci. 88(6) (1999) 592.
D. S. Jones, C. R. Irwin, C. R. Irwin, A. F. Brown, A. D. Woolfson, W. A. Coulter and C. Mcclelland, J. Cont. Rel. 67(2–3) (2000) 357.
N. J. Medlicott, M. J. Rathbone, I. G. Tucker and D. W. Holborow, Adv. Drug Deliv. Rev. 13(1994) 181.
A. D. Woolfson, K. Malcolm, P. A. Mccarron and D. S. Jones, in ‘Polymeric Biomaterials’, edited by S. Dumitriu. (Marcel Dekker, 2002), pp. 1063-1083.
A. D. Woolfson, D. F. Mccafferty, C. R. Mccallion, E. T. Mcadams and J. Anderson, J. Appl. Polym. Sci. 58 (1995) 1291.
G. Ponchel, F. Touchard, D. Wouessidjewe, D. Duchene and N. A. Peppas, Int J. Pharm. 38 (1987) 65.
Y. Y. Iscan, Y. Capan, S. Senel, M. F. Sahin, S. Kes, D. Duchene and A. A. Hincal, STP Pharma Sci. 8 (1998) 357.
N. J. Medlicott, D. Ferry, I. G. Tucker, M. J. Rathbone, D. Holborow and D. S. Jones, J. Liq. Chrom. 17(7) (1994) 1605.
N. A. Peppas, Pharmaceut. Acta Helv. 60 (1985) 110.
N. J. Medlicott, M. J. Rathbone, I. G. Tucker, D. Holborow and D. S. Jones, J. Cont. Rel. 61(3) (1999) 337.
M. Addy, J. Clin. Periodontol. 13 (1986) 957.
P. Bonesvoll and P. Gjermo, Arch. Oral Biol. 23 (1978) 289.
P. Bonesvoll, Arch. Oral Biol. 23 (1978) 295.
L. FlÖtra, P. Gjermo, G. RÖlla and J. Waerhaug, Scand. J. Dent. Res. 79 (1971) 119.
D. M. Foulkes, J. Periodont Res. 8(12) (1973) 55.
D. S. Jones, A. F. Brown and A. D. Woolfson, J. Pharm. Sci. 90(12) (2001) 1978.
A. E. Collins and P. B. Deasy, J. Pharm. Sci. 79(2) (1990) 116.
J. M. Gu, J. R. Robinson and S. H. S. Leing, CRC Crit. Rev. Ther. Drug Carrier Sys. 5 (1988) 21.
S. A. Mortazavi and J. D. Smart, J. Pharm. Pharmacol. 46 (1994) 86.
D. S. Jones, A. D. Woolfson and A. F. Brown, Int. J. Pharm. 151 (1997) 223.
I. G. Needleman, F. C. Smales and G. P. Martin, J. Clin. Periodont. 24 (1997) 394.
C. Remunanlopez, A. Portero, J. L. Vilajato and M. J. Alonso, J. Cont. Rel. 55 (1998) 143.
D. S. Jones, M. S. Lawlor and A. D. Woolfson, J. Pharm. Sci. 91(9) (2002) 2090.
D. S. Jones, M. S. Lawlor and A. D. Woolfson, J. Pharm. Sci. In press.
H. Blancofuente, S. Anguianolgea, F. J. Oteroespinar and J. Blancomendez, Int. J. Pharm. 142 (1996) 169.
R. Nguyenxuan, A. Towart, Y. Terras, P. Jacques, P. Buri and R. Gurny, Eur. J. Pharm. Biopharm. 42 (1996) 289.
J. D. Smart, I. W. Kellaway and H. E. C. Worthington, J. Pharm. Pharmacol. 36 (1984) 295.
C. F. Wong, K. H. Yuen and K. K. Peh, Int. J. Pharm. 178 (1999) 11.
N. Cvetkovic, M. Nesic, V. Moracic and M. Rosic, Pharmazie 52 (1997) 536.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Irwin, C.R., McCullough, K.C. & Jones, D.S. Chlorhexidine-containing mucoadhesive polymeric compacts designed for use in the oral cavity: an examination of their physical properties, in vitro/in vivo drug release properties and clinical acceptability. Journal of Materials Science: Materials in Medicine 14, 825–832 (2003). https://doi.org/10.1023/A:1025637106818
Issue Date:
DOI: https://doi.org/10.1023/A:1025637106818